4th year student in Chemistry
Alzheimer’s disease is a neurodegenerative disorder characterised by the deposition of insoluble aggregates of the peptide amyloid-beta. There is currently no disease-modifying treatment, in part due to an incomplete understanding of how to prevent the aggregates from forming. My work focuses on developing a strategy to systematically develop and optimise small molecules to prevent the aggregation of amyloid-beta. This work has led to the opening of a spin-off biotechnology therapeutics company, and this strategy is going to be generally applied to drug discovery efforts in other protein misfolding diseases, such as Parkinson’s disease, and Type II diabetes.
Find out about the winners awarded in previous years: